SCHEMBL25872182

SCHEMBL25872182

N#Cc1ccc(-c2cc(-c3ccccc3)c(-c3ccc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc3)cc2-c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.61
ABCB1 P08183 5/20 0.54
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HPGD P15428 2/20 0.53
NTSR1 P30989 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
GABRA1 P14867 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
GABRA3 P34903 1/20 0.51
MYC P01106 1/20 0.51
KDM4E B2RXH2 2/20 0.50
ADORA1 P30542 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ADORA2A P29274 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25872120 0.92 ABCG2 (0.58) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL25872183 0.91 ABCG2 (0.56) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL19939368 0.91 ABCG2 (0.58) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL19939376 0.91 ABCG2 (0.58) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL23383851 0.90 ABCG2 (0.64) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL23383854 0.90 ABCG2 (0.64) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL19939375 0.89 ABCG2 (0.57) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL22115123 0.89 ABCG2 (0.57) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL18010668 0.89 ABCG2 (0.57) ABCG2ABCB1MEN1KMT2AHPGD
SCHEMBL19939367 0.89 ABCG2 (0.57) ABCG2ABCB1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212141-A1 Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same NOVALED GMBH (DE) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212141-A1 Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same AOX1, ICMT, OCIAD2 ABCG2 3068/4885ABCB1 2820/4885MEN1 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.